Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04546074
Status:
RECRUITING
Last Update Posted:
2023-10-03
First Post:
2020-08-29
Brief Title:
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
Sponsor:
Keio University
Organization:
Keio University
Organization Data
Organization:
Keio University
Class:
OTHER
Study ID:
N20190002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Keio University
Lead Sponsor Class:
OTHER
Responsible Party:
Takeru Funakoshi
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Keio University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |
| Ohara Pharmaceutical Co Ltd | INDUSTRY |